Aurobindo Pharma has inaugurated TheraNym, one of India's largest dedicated biologics contract manufacturing organisations (CMO). TheraNym represents Aurobindo Pharma’s bold and strategic foray into biologics contract manufacturing - a segment that is growing worldwide and is increasingly vital to meeting global demand for biologic therapies.
The facility is strategically located in Borapatla approximately 45 minutes from the Hyderabad’s bustling Financial District and is equipped with 15 KL bioreactors, advanced downstream processing suites, aseptic fill-finish capabilities, and quality control laboratories. TheraNym has been designed with international regulatory expectations in mind. The facility is intended to support MSD supply chain, both domestic and export markets, subject to applicable approvals and customer requirements.
Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.
